Our Location
Email Us
Phone Us
Manufacturing Process
Home / Manufacturing Process
Manufacturing Process of Oxy-Rx™
Control source of raw material - donated bovine blood
Red blood cells extraction
Within 24 hours after donation
Hemoglobin (Hb) (Oxygen-carrying molecule) is cleaned out of red blood cells.
- Produces 99.9% pure form of active hemoglobin (stabilized) (no endotoxin)
- Only clinically proven investigative material to achieve phase 3 status worldwide with competent authorities
- Purification and viral/TSE burden reduction to current FDA standards can be achieved with new/proprietary Process Scale HPLC/membrane methods at commercial scale
- Results in significant clinical and commercial advantages
Stabilized Hb Dimer 128 - 250 kD
Modified–hemoglobin Protein Active Oxygen Carrier (M-HPAOC)
Stability is 5+ years at room temperature
Native Hb molecule 64-68 kD
Patented, Proprietary Manufacturing Process
Collect controlled source bovine RBC's
Isolate Hemoglobin protein
Purify and crosslink
Proprietary Ultrapure™ Bioengineering
Cost-effective globally available redundant modular automated technology for biopharma.
Proprietary Manufacturing Process
For further information on OXY-Rx™ please contact us.
We would be happy to discuss it further.
0207 034 3300
We’d like to hear from you
Fitzrovia Hospital,
13-14 Fitzroy Square London, W1T 6AH
Please write to us
About
Markets
Press Releases
Contact